Literature DB >> 12933503

Hepatocellular carcinoma supplied by portal flow after repeated transcatheter arterial chemoembolization.

Seung Hong Choi1, Jin Wook Chung, Hye Seung Lee.   

Abstract

Entities:  

Mesh:

Year:  2003        PMID: 12933503     DOI: 10.2214/ajr.181.3.1810889

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


× No keyword cloud information.
  4 in total

1.  Evaluation of transarterial chemoembolization combined with percutaneous ethanol ablation for large hepatocellular carcinoma.

Authors:  Fei Gao; Yang-Kui Gu; Wei-Jun Fan; Liang Zhang; Jin-Hua Huang
Journal:  World J Gastroenterol       Date:  2011-07-14       Impact factor: 5.742

2.  Repeated transcatheter arterial chemoembolization is safe for hepatocellular carcinoma in cirrhotic patients with transjugular intrahepatic portosystemic shunt.

Authors:  Zhu Wang; Hailong Zhang; He Zhao; Xiaoze Wang; Jiaywei Tsauo; Xuefeng Luo; Xiao Li
Journal:  Diagn Interv Radiol       Date:  2014-11       Impact factor: 2.630

3.  Risk factors for local tumor recurrence after segmental transarterial chemoembolization for hepatocellular carcinoma: the importance of tumor located in the segmental border zone.

Authors:  Yun Ku Cho; Jin Wook Chung; Yong-Sik Ahn; Yoon-Ok Park; Jae Kyun Kim; Jong-Hoon Byun
Journal:  Korean J Radiol       Date:  2006 Oct-Dec       Impact factor: 3.500

4.  Survival of infiltrative hepatocellular carcinoma patients with preserved hepatic function after treatment with transarterial chemoembolization.

Authors:  Eun Sun Jang; Jung-Hwan Yoon; Jin Wook Chung; Eun Ju Cho; Su Jong Yu; Jeong-Hoon Lee; Yoon Jun Kim; Hyo-Suk Lee; Chung Yong Kim
Journal:  J Cancer Res Clin Oncol       Date:  2013-01-03       Impact factor: 4.553

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.